← All causality assessments
Causality assessment · Causality: well established

Corticosteroids (prednisolone) and Avascular necrosis of bone: is the FAERS signal real?

n=1,064 co-reports · PRR 3.8 · ROR 3.9
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Causality: well established

Corticosteroids (prednisolone) ↔ Avascular necrosis of bone

n=1,064 co-reports · PRR 3.8 · ROR 3.9

Systemic corticosteroids such as prednisolone are a leading cause of osteonecrosis (avascular necrosis), especially of the hip, and the risk rises with higher doses and longer courses — even short high-dose bursts have been implicated. The mechanism involves impaired blood supply and altered fat metabolism in bone. The 1,064 co-reports (PRR 3.8) are driven by the enormous number of patients who receive steroids for inflammatory and autoimmune conditions.

Regulatory basis: corticosteroid prescribing information (osteonecrosis, osteoporosis; monitoring advice). Established glucocorticoid-osteonecrosis literature.

Bradford Hill viewpointStatusNote
Temporality (necessary)metOsteonecrosis typically appears months after starting or escalating steroids
StrengthpartialPRR 4 with a large co-report count — a modest but broad signal
ConsistencymetReproduced across decades of cohort and case series
SpecificitymetA recognised corticosteroid effect, not unique to prednisolone
Biological gradientpartialDose- and duration-related
PlausibilitymetImpaired bone blood supply and fat-metabolism changes are the mechanisms
CoherencemetCoheres with the labelled skeletal warnings and monitoring
ExperimentpartialDechallenge (steroid withdrawal) does not reverse established lesions; no randomized trial
AnalogymetAnalogous to osteonecrosis from other glucocorticoids and in transplant/immunosuppression

This page's own qualitative read, not an automated/citation-gated assessment.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for prednisolone captured osteonecrosis; it appears months after steroid exposure and is identified through imaging and cohort studies rather than a trial AE table.